Functional Microbiomics, Inflammation and Pathogenicity

功能微生物组学、炎症和致病性

基本信息

  • 批准号:
    10492096
  • 负责人:
  • 金额:
    $ 234.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract In the past few decades, the fields of microbiology and immunology have undergone a renaissance, driven in part by technological advances establishing that the human microbiome can play a role in a number of fundamental aspects of human health and disease, in many instances through the interface with host innate immunity. The immune system functions to restrict the potential for damage caused by the microbiota while simultaneously minimizing destructive inflammatory responses. Disruption of the intensity, duration or physical location of inflammation, however, can contribute to disease. Advances in our understanding of the microbiome, and its regulation by environmental factors, along with a realization that inflammatory processes are at the core of a number of common diseases, necessitates a cross-disciplinary perspective that accommodates the host- microbe interaction in toto. The major goal of this Phase 2 Cobre is to continue to develop and expand our thematic multidisciplinary research center for the study of the interface between the microbiome, inflammation and pathogenicity within a framework to develop the careers of junior investigators. We have assembled a team of junior investigators with complementary expertise and outstanding potential, and have partnered these project leaders with well-qualified and dedicated mentors. An integrated set of projects will make novel connections between inflammatory processes and bacterial pathogenicity, and establish the basis for the development of novel therapeutics and delivery methods. We will create a multidisciplinary program in research, training, mentoring and career development that will facilitate and accelerate the transition of junior faculty to independent extramural funded status. Research will be support by a Functional Microbiomics Core that will provide germ free animal facilities, anaerobic culture capability, microbiome sequencing and bioinformatics, assay of inflammatory markers, along with whole animal imaging and intravital microscopy. An Administrative Core will co-ordinate activities and provide additional biostatistical support, along with a Pilot Project program to ensure a pipeline of investigators. Institutional commitment through a university funded Center will ensure sustainability of the thematic research program.
项目总结/文摘

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard J Lamont其他文献

The problem and cultural background of Runic Scripts of Old Turkic Epitaphs
古突厥墓志铭符文问题及文化背景
Smoking alters the antigenicity and infectivity of Porphyromonas gingivalis
  • DOI:
    10.1186/1617-9625-12-s1-a14
  • 发表时间:
    2014-06-06
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    Iris Zeller;Justin A Hutcherson;Richard J Lamont;Donald R Demuth;Pinar Gumus;Nejat Nizam;Nurcan Buduneli;David A Scott
  • 通讯作者:
    David A Scott
Nicotinic augmentation of anti-inflammatory GSK3b signaling
  • DOI:
    10.1186/1617-9625-12-s1-a15
  • 发表时间:
    2014-06-06
  • 期刊:
  • 影响因子:
    1.900
  • 作者:
    David A Scott;Richard J Lamont;Akhilesh Kumar;Huizhi Wang
  • 通讯作者:
    Huizhi Wang
腫瘍微小環境において,腫瘍由来のmiRX により血管内皮はIL-6 をオートクラインで利用し,薬剤耐性や幹細胞性を獲得している
在肿瘤微环境中,血管内皮由于肿瘤来源的miRX而自分泌IL-6以获得耐药性和干细胞性。
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiroaki Inaba;Atsuo Amano;Richard J Lamont;Yukitaka Murakami;鳥居ちさほ,秋山廣輔,川本泰輔,間石奈湖,鄭 漢忠,進藤正信,樋田泰浩,樋田京子
  • 通讯作者:
    鳥居ちさほ,秋山廣輔,川本泰輔,間石奈湖,鄭 漢忠,進藤正信,樋田泰浩,樋田京子
ホワイトカラー農民の出現-タイ南部のアブラヤシ栽培と人々の生活世界-
白领农民的崛起-泰国南部的油棕种植与人们的生活世界-
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiroaki Inaba;Atsuo Amano;Richard J Lamont;Yukitaka Murakami;Takashi OSAWA;安里和晃;藤田渡
  • 通讯作者:
    藤田渡

Richard J Lamont的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard J Lamont', 18)}}的其他基金

COBRE-Administrative Core
COBRE-管理核心
  • 批准号:
    10349567
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
Inflammation and Pathogenesis Training Program
炎症与发病机制培训计划
  • 批准号:
    10438562
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
Functional Microbiomics, Inflammation and Pathogenicity
功能微生物组学、炎症和致病性
  • 批准号:
    10797084
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
Inflammation and Pathogenesis Training Program
炎症与发病机制培训计划
  • 批准号:
    10153668
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
Functional Microbiomics, Inflammation and Pathogenicity
功能微生物组学、炎症和致病性
  • 批准号:
    10852188
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
FMIP COBRE Administrative Core
FMIP COBRE 管理核心
  • 批准号:
    10492097
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
Functional Microbiomics, Inflammation and Pathogenicity
功能微生物组学、炎症和致病性
  • 批准号:
    10349566
  • 财政年份:
    2018
  • 资助金额:
    $ 234.75万
  • 项目类别:
P.gingivalis interactions with gingival epithelial cells
牙龈卟啉单胞菌与牙龈上皮细胞的相互作用
  • 批准号:
    8984161
  • 财政年份:
    2014
  • 资助金额:
    $ 234.75万
  • 项目类别:
P.gingivalis interactions with gingival epithelial cells
牙龈卟啉单胞菌与牙龈上皮细胞的相互作用
  • 批准号:
    8773766
  • 财政年份:
    2014
  • 资助金额:
    $ 234.75万
  • 项目类别:
P.gingivalis interactions with gingival epithelial cells
牙龈卟啉单胞菌与牙龈上皮细胞的相互作用
  • 批准号:
    9197283
  • 财政年份:
    2014
  • 资助金额:
    $ 234.75万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
    Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
  • 批准号:
    23H02155
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
  • 批准号:
    10788032
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
  • 批准号:
    23K14742
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
  • 批准号:
    10864719
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
  • 批准号:
    10586562
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
  • 批准号:
    10593224
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
  • 批准号:
    23K06589
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
  • 批准号:
    10623380
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
  • 批准号:
    10735148
  • 财政年份:
    2023
  • 资助金额:
    $ 234.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了